{"transactions":[{"id":1169859,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-17T20:07:30.000Z","date":"2025-04-16","kind":"sale","planned":false,"acquired":false,"shares":8321,"price":14.89,"value":123899.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 12, 2023, the holder was granted 243,832 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 14, 2023, of which 15,240 of these RSUs vested on April 12,\n2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is\nmandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from  $14.74 - $15.40 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":1178191,"source":{"system":"sec-edgar","filing":"0001764013-25-000075","document":"wk-form4_1744920441.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000075/wk-form4_1744920441.xml","form_type":"4"}},{"id":1173325,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-11T20:05:03.000Z","date":"2025-04-09","kind":"sale","planned":false,"acquired":false,"shares":28094,"price":12.99,"value":364941.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 2, 2024, the holder was granted 160,534 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 4, 2024, of which 40,133 of these RSUs vested on April\n2, 2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is\nmandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.75 - $13.26 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":1186512,"source":{"system":"sec-edgar","filing":"0001764013-25-000066","document":"wk-form4_1744401896.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000066/wk-form4_1744401896.xml","form_type":"4"}},{"id":1179761,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-03T20:46:54.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":374395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the options will vest as to 25% of the shares on April 1, 2026 and the remainder will vest in 36 substantially equal monthly installments over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":374395,"derivative":{"exercise_price":15.2,"expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":374395},"source":{"system":"sec-edgar","filing":"0001764013-25-000049","document":"wk-form4_1743713207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000049/wk-form4_1743713207.xml","form_type":"4"}},{"id":1179760,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-03T20:46:54.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":265820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the units on April 1, 2026, and the remainder will vest in substantially equal installments on a quarterly basis over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":1214606,"source":{"system":"sec-edgar","filing":"0001764013-25-000049","document":"wk-form4_1743713207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000049/wk-form4_1743713207.xml","form_type":"4"}},{"id":1253056,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-21T21:04:19.000Z","date":"2025-02-19","kind":"sale","planned":false,"acquired":false,"shares":15439,"price":20.86,"value":322057.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 17, 2022, the holder was granted 451,264 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on August 19, 2022, of which 28,204 of these RSUs vested on\nFebruary 17, 2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs.\nThe sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the\nReporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.51 - $21.09 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":948786,"source":{"system":"sec-edgar","filing":"0001764013-25-000030","document":"wk-form4_1740171852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000030/wk-form4_1740171852.xml","form_type":"4"}},{"id":1300177,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-17T21:04:33.000Z","date":"2025-01-15","kind":"sale","planned":false,"acquired":false,"shares":415,"price":24.19,"value":10038.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 12, 2023, the holder was granted 243,832 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 14, 2023, of which 15,239 of these RSUs vested on January 12,\n2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is\nmandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.13 - $24.21 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":964225,"source":{"system":"sec-edgar","filing":"0001764013-25-000013","document":"wk-form4_1737147867.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000013/wk-form4_1737147867.xml","form_type":"4"}},{"id":1300176,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-17T21:04:33.000Z","date":"2025-01-15","kind":"sale","planned":false,"acquired":false,"shares":8352,"price":23.81,"value":198861.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 12, 2023, the holder was granted 243,832 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 14, 2023, of which 15,239 of these RSUs vested on January 12,\n2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is\nmandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.13 - $24.07 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":964640,"source":{"system":"sec-edgar","filing":"0001764013-25-000013","document":"wk-form4_1737147867.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000013/wk-form4_1737147867.xml","form_type":"4"}},{"id":1305287,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-10T21:11:02.000Z","date":"2025-01-08","kind":"sale","planned":false,"acquired":false,"shares":5105,"price":24.1,"value":123030.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 19, 2021, the holder was granted 132,500 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on March 23, 2021, of which 8,282 of these RSUs vested on January 1,\n2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is\nmandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting\nPerson."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.91 - $24.60 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":972992,"source":{"system":"sec-edgar","filing":"0001764013-25-000003","document":"wk-form4_1736543457.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000003/wk-form4_1736543457.xml","form_type":"4"}},{"id":1354449,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-11-22T21:08:23.000Z","date":"2024-11-20","kind":"sale","planned":false,"acquired":false,"shares":16692,"price":25.45,"value":424811.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 17, 2022, the holder was granted 451,264 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on August 19, 2022, of which 28,204 of these RSUs vested on November 17, 2024. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.91 - $25.81 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":978097,"source":{"system":"sec-edgar","filing":"0001764013-24-000193","document":"wk-form4_1732309693.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000193/wk-form4_1732309693.xml","form_type":"4"}},{"id":1384132,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-10-18T20:31:13.000Z","date":"2024-10-16","kind":"sale","planned":false,"acquired":false,"shares":9095,"price":28.79,"value":261845.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 12, 2023, the holder was granted 243,832 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 14, 2023, of which 15,240 of these RSUs vested on October 12, 2024. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.31 - $29.14 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":994789,"source":{"system":"sec-edgar","filing":"0001764013-24-000174","document":"wk-form4_1729283466.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000174/wk-form4_1729283466.xml","form_type":"4"}},{"id":1387584,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-10-11T20:02:43.000Z","date":"2024-10-09","kind":"sale","planned":false,"acquired":false,"shares":4460,"price":29.56,"value":131837.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 19, 2021, the holder was granted 132,500 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on March 23, 2021, of which 8,281 of these RSUs vested on October 1, 2024. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.28 - $29.85 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1003884,"source":{"system":"sec-edgar","filing":"0001764013-24-000165","document":"wk-form4_1728676955.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000165/wk-form4_1728676955.xml","form_type":"4"}},{"id":1424326,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-23T20:07:18.000Z","date":"2024-08-21","kind":"sale","planned":false,"acquired":false,"shares":598,"price":32.32,"value":19327.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 17, 2022, the holder was granted 451,264 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on August 19, 2022, of which 28,204 of these RSUs vested on August 17, 2024. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.28 - $32.37 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1008344,"source":{"system":"sec-edgar","filing":"0001764013-24-000156","document":"wk-form4_1724443632.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000156/wk-form4_1724443632.xml","form_type":"4"}},{"id":1424325,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-23T20:07:18.000Z","date":"2024-08-21","kind":"sale","planned":false,"acquired":false,"shares":14470,"price":31.84,"value":460724.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 17, 2022, the holder was granted 451,264 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on August 19, 2022, of which 28,204 of these RSUs vested on August 17, 2024. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.26 - $32.25 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1008942,"source":{"system":"sec-edgar","filing":"0001764013-24-000156","document":"wk-form4_1724443632.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000156/wk-form4_1724443632.xml","form_type":"4"}},{"id":1451221,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-07-19T21:36:22.000Z","date":"2024-07-17","kind":"sale","planned":false,"acquired":false,"shares":510,"price":30.55,"value":15580.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 12, 2023, the holder was granted 243,832 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 14, 2023, of which 15,239 of these RSUs vested on July 12, 2024. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.30 - $30.84 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1023412,"source":{"system":"sec-edgar","filing":"0001764013-24-000133","document":"wk-form4_1721424975.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000133/wk-form4_1721424975.xml","form_type":"4"}},{"id":1451220,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-07-19T21:36:22.000Z","date":"2024-07-17","kind":"sale","planned":false,"acquired":false,"shares":8175,"price":29.64,"value":242307.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 12, 2023, the holder was granted 243,832 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 14, 2023, of which 15,239 of these RSUs vested on July 12, 2024. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.30 - $30.28 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1023922,"source":{"system":"sec-edgar","filing":"0001764013-24-000133","document":"wk-form4_1721424975.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000133/wk-form4_1721424975.xml","form_type":"4"}},{"id":1456941,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-07-10T21:04:37.000Z","date":"2024-07-09","kind":"sale","planned":false,"acquired":false,"shares":4619,"price":28.06,"value":129609.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 19, 2021, the holder was granted 132,500 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on March 23, 2021, of which 8,281 of these RSUs vested on July 1, 2024. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.48 - $28.42 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1032097,"source":{"system":"sec-edgar","filing":"0001764013-24-000125","document":"wk-form4_1720645470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000125/wk-form4_1720645470.xml","form_type":"4"}},{"id":1494780,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-03T20:30:09.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":2783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 30, 2024, 2,783 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On May 30, 2024, 2,783 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":2783,"source":{"system":"sec-edgar","filing":"0000950170-24-068030","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024068030/ownership.xml","form_type":"4"}},{"id":1502135,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-24T20:15:51.000Z","date":"2024-05-22","kind":"sale","planned":false,"acquired":false,"shares":16163,"price":29.65,"value":479232.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 17, 2022, the holder was granted 451,264 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on August 19, 2022, of which 28,204 of these RSUs vested on May 17, 2024. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.31 - $30.02 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1036716,"source":{"system":"sec-edgar","filing":"0001764013-24-000098","document":"wk-form4_1716581737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000098/wk-form4_1716581737.xml","form_type":"4"}},{"id":1508575,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-20T21:00:43.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":2783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":2783,"derivative":{"exercise_price":45.92,"expiration_date":"2034-05-16","underlying":"Common Stock","underlying_shares":2783},"source":{"system":"sec-edgar","filing":"0001209191-24-005676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919124005676/doc4.xml","form_type":"4"}},{"id":1538440,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-04-19T21:57:13.000Z","date":"2024-04-17","kind":"sale","planned":false,"acquired":false,"shares":7714,"price":29.94,"value":230957.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 12, 2023, the holder was granted 243,832 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 14, 2023, of which 60,958 of these RSUs vested on April 12, 2024. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.43 - $30.20 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1052879,"source":{"system":"sec-edgar","filing":"0001764013-24-000075","document":"wk-form4_1713563823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000075/wk-form4_1713563823.xml","form_type":"4"}},{"id":1538439,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-04-19T21:57:13.000Z","date":"2024-04-17","kind":"sale","planned":false,"acquired":false,"shares":26365,"price":28.8,"value":759312.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 12, 2023, the holder was granted 243,832 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 14, 2023, of which 60,958 of these RSUs vested on April 12, 2024. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.43 - $29.40 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1060593,"source":{"system":"sec-edgar","filing":"0001764013-24-000075","document":"wk-form4_1713563823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000075/wk-form4_1713563823.xml","form_type":"4"}},{"id":1543831,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-04-10T20:14:09.000Z","date":"2024-04-09","kind":"sale","planned":false,"acquired":false,"shares":4807,"price":31.18,"value":149882.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 19, 2021, the holder was granted 132,500 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on March 23, 2021, of which 8,281 of these RSUs vested on April 1, 2024. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.73 - $31.45 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1086958,"source":{"system":"sec-edgar","filing":"0001764013-24-000069","document":"wk-form4_1712780038.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000069/wk-form4_1712780038.xml","form_type":"4"}},{"id":1547829,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-04T20:23:58.000Z","date":"2024-04-02","kind":"grant","planned":false,"acquired":true,"shares":200667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the options will vest as to 25% of the shares on April 2, 2025 and the remainder will vest in 36 substantially equal monthly installments over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":200667,"derivative":{"exercise_price":30.78,"expiration_date":"2034-04-02","underlying":"Common Stock","underlying_shares":200667},"source":{"system":"sec-edgar","filing":"0001764013-24-000044","document":"wk-form4_1712262227.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000044/wk-form4_1712262227.xml","form_type":"4"}},{"id":1547828,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-04-04T20:23:58.000Z","date":"2024-04-02","kind":"grant","planned":false,"acquired":true,"shares":160534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the units on April 2, 2025, and the remainder will vest in substantially equal installments on a quarterly basis over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":1091765,"source":{"system":"sec-edgar","filing":"0001764013-24-000044","document":"wk-form4_1712262227.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000044/wk-form4_1712262227.xml","form_type":"4"}},{"id":1622708,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-23T21:11:14.000Z","date":"2024-02-22","kind":"sale","planned":false,"acquired":false,"shares":13454,"price":36.15,"value":486362.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 17, 2022, the holder was granted 451,264 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on August 19, 2022, of which 28,204 of these RSUs vested on February 17, 2024. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.85 - $36.60 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":931231,"source":{"system":"sec-edgar","filing":"0001764013-24-000037","document":"wk-form4_1708722641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000037/wk-form4_1708722641.xml","form_type":"4"}},{"id":1682813,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-01-09T21:18:35.000Z","date":"2024-01-05","kind":"sale","planned":false,"acquired":false,"shares":3824,"price":38.59,"value":147568.16,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 19, 2021, the holder was granted 132,500 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on March 23, 2021, of which 8,282 of these RSUs vested on January 1, 2024. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.59 - $39.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":944685,"source":{"system":"sec-edgar","filing":"0001764013-24-000006","document":"wk-form4_1704835104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000006/wk-form4_1704835104.xml","form_type":"4"}},{"id":1730338,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-11-24T19:55:26.000Z","date":"2023-11-22","kind":"sale","planned":false,"acquired":false,"shares":616,"price":33.52,"value":20648.32,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 17, 2022, the holder was granted 451,264 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on August 19, 2022, of which 28,204 of these RSUs vested on November 17, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $33.46 - $33.68 per share, inclusive. The Reporting Person undertakes to provide to\nthe Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":948509,"source":{"system":"sec-edgar","filing":"0001764013-23-000146","document":"wk-form4_1700855717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401323000146/wk-form4_1700855717.xml","form_type":"4"}},{"id":1730337,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-11-24T19:55:26.000Z","date":"2023-11-22","kind":"sale","planned":false,"acquired":false,"shares":15601,"price":32.75,"value":510932.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 17, 2022, the holder was granted 451,264 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on August 19, 2022, of which 28,204 of these RSUs vested on November 17, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $32.43 - $33.38 per share, inclusive. The Reporting Person undertakes to provide to\nthe Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":949125,"source":{"system":"sec-edgar","filing":"0001764013-23-000146","document":"wk-form4_1700855717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401323000146/wk-form4_1700855717.xml","form_type":"4"}},{"id":1763672,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-10-06T21:10:08.000Z","date":"2023-10-05","kind":"sale","planned":false,"acquired":false,"shares":4345,"price":36.39,"value":158114.55,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 19, 2021, the holder was granted 132,500 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on March 23, 2021, of which 8,281 of these RSUs vested on October 1, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $35.92 - $36.83 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4"}],"balance_after":964726,"source":{"system":"sec-edgar","filing":"0001764013-23-000117","document":"wk-form4_1696626599.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401323000117/wk-form4_1696626599.xml","form_type":"4"}},{"id":1763671,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-10-06T21:10:08.000Z","date":"2023-10-05","kind":"sale","planned":false,"acquired":false,"shares":894,"price":35.54,"value":31772.76,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 19, 2021, the holder was granted 132,500 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on March 23, 2021, of which 8,281 of these RSUs vested on October 1, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $34.90 - $35.89 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":969071,"source":{"system":"sec-edgar","filing":"0001764013-23-000117","document":"wk-form4_1696626599.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401323000117/wk-form4_1696626599.xml","form_type":"4"}},{"id":1790910,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-01T20:08:12.000Z","date":"2023-08-30","kind":"sale","planned":false,"acquired":false,"shares":5908,"price":22.48,"value":132811.84,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 17, 2022, the holder was granted 451,264 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on August 19, 2022, of which 112,816 of these RSUs vested on August 17, 2023. Settlement with respect to the 112,816 vested RSUs was deferred and amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.43 - $22.59 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":969965,"source":{"system":"sec-edgar","filing":"0001764013-23-000107","document":"wf-form4_169359887938473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401323000107/wf-form4_169359887938473.xml","form_type":"4"}},{"id":1790909,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-01T20:08:12.000Z","date":"2023-08-30","kind":"sale","planned":false,"acquired":false,"shares":50866,"price":21.97,"value":1117526.02,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 17, 2022, the holder was granted 451,264 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on August 19, 2022, of which 112,816 of these RSUs vested on August 17, 2023. Settlement with respect to the 112,816 vested RSUs was deferred and amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.43 - $22.41 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":975873,"source":{"system":"sec-edgar","filing":"0001764013-23-000107","document":"wf-form4_169359887938473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401323000107/wf-form4_169359887938473.xml","form_type":"4"}},{"id":1805965,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-16T20:11:12.000Z","date":"2023-08-14","kind":"sale","planned":false,"acquired":false,"shares":11314,"price":22.04,"value":249360.56,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 3, 2021, the holder was granted 570,613 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on August 4, 2021, of which the remaining 356,633 of these RSUs vested on August 3, 2023. As previously reported on a Form 4 filed on August 8, 2023, settlement was deferred with respect to 178,317 of the vested RSUs. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the remaining settlement of 178,317 of the RSUs and do not represent a discretionary sale by the holder."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.88 - $22.18 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1026739,"source":{"system":"sec-edgar","filing":"0001764013-23-000094","document":"wf-form4_169221665635652.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401323000094/wf-form4_169221665635652.xml","form_type":"4"}},{"id":1805964,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-16T20:11:12.000Z","date":"2023-08-14","kind":"sale","planned":false,"acquired":false,"shares":91744,"price":21.34,"value":1957816.96,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 3, 2021, the holder was granted 570,613 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on August 4, 2021, of which the remaining 356,633 of these RSUs vested on August 3, 2023. As previously reported on a Form 4 filed on August 8, 2023, settlement was deferred with respect to 178,317 of the vested RSUs. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the remaining settlement of 178,317 of the RSUs and do not represent a discretionary sale by the holder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.88 - $21.85 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1038053,"source":{"system":"sec-edgar","filing":"0001764013-23-000094","document":"wf-form4_169221665635652.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401323000094/wf-form4_169221665635652.xml","form_type":"4"}},{"id":1812991,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-08T20:44:48.000Z","date":"2023-08-07","kind":"sale","planned":false,"acquired":false,"shares":101339,"price":21.73,"value":2202096.47,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 3, 2021, the holder was granted 570,613 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on August 4, 2021, of which the remaining 356,633 of these RSUs vested on August 3, 2023. Settlement was deferred with respect to 178,317 of the vested RSUs. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of 178,316 of the RSUs and do not represent a discretionary sale by the holder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.26 - $22.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1129797,"source":{"system":"sec-edgar","filing":"0001764013-23-000087","document":"wf-form4_169152738079375.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401323000087/wf-form4_169152738079375.xml","form_type":"4"}},{"id":1830346,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-07-13T21:11:50.000Z","date":"2023-07-12","kind":"sale","planned":false,"acquired":false,"shares":3233,"price":19.73,"value":63787.09,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 19, 2021, the holder was granted 132,500 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on March 23, 2021, of which 8,281 of these RSUs vested on July 1, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.39 - $20.12 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1231136,"source":{"system":"sec-edgar","filing":"0001764013-23-000078","document":"wf-form4_168928269599746.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401323000078/wf-form4_168928269599746.xml","form_type":"4"}},{"id":1882154,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-22T20:24:56.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest 100% on the one year anniversay from the date of grant."}],"balance_after":5300,"derivative":{"exercise_price":9.96,"expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001209191-23-031460","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919123031460/doc4.xml","form_type":"4"}},{"id":1917268,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-04-19T20:09:15.000Z","date":"2023-04-18","kind":"sale","planned":false,"acquired":false,"shares":3395,"price":15.27,"value":51841.65,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 19, 2021, the holder was granted 132,500 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on March 23, 2021, of which 8,281 of these RSUs vested on April 1, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.08 - $15.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1234369,"source":{"system":"sec-edgar","filing":"0001764013-23-000049","document":"wf-form4_168193494493140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401323000049/wf-form4_168193494493140.xml","form_type":"4"}},{"id":1919625,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-14T20:14:20.000Z","date":"2023-04-12","kind":"grant","planned":false,"acquired":true,"shares":316585,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on April 12, 2024 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date."}],"balance_after":316585,"derivative":{"exercise_price":14.7,"expiration_date":"2033-04-12","underlying":"Common Stock","underlying_shares":316585},"source":{"system":"sec-edgar","filing":"0001764013-23-000038","document":"wf-form4_168150324964962.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401323000038/wf-form4_168150324964962.xml","form_type":"4"}},{"id":1919624,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-04-14T20:14:20.000Z","date":"2023-04-12","kind":"grant","planned":false,"acquired":true,"shares":243832,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the number of shares underlying restricted stock units awards (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest over four years, with 25% of the RSUs vesting on April 12, 2024 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date."}],"balance_after":1237764,"source":{"system":"sec-edgar","filing":"0001764013-23-000038","document":"wf-form4_168150324964962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401323000038/wf-form4_168150324964962.xml","form_type":"4"}},{"id":2054815,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-13T13:21:55.000Z","date":"2023-01-11","kind":"sale","acquired":false,"shares":4021,"price":16.8,"value":67552.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 19, 2021, the holder was granted 132,500 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on March 23, 2021, of which 8,282 of these RSUs vested on January 1, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.76 - $16.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":993932,"source":{"system":"sec-edgar","filing":"0001764013-23-000012","document":"wf-form4_167361610100577.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401323000012/wf-form4_167361610100577.xml","form_type":"4"}},{"id":2136386,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-10-17T12:57:50.000Z","date":"2022-10-13","kind":"sale","acquired":false,"shares":2793,"price":9.18,"value":25639.74,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 19, 2021, the holder was granted 132,500 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on March 23, 2021, of which 8,281 of these RSUs vested on October 1, 2022 and the remainder of the RSUs vest in quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.18 - $9.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":997953,"source":{"system":"sec-edgar","filing":"0001764013-22-000130","document":"wf-form4_166601145413186.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401322000130/wf-form4_166601145413186.xml","form_type":"4"}},{"id":2149413,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-29T21:06:31.000Z","date":"2022-09-28","kind":"sale","acquired":false,"shares":1605,"price":4.67,"value":7495.35,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 19, 2021, the holder was granted 132,500 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on March 23, 2021, of which 2,760 of these RSUs vested on September 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder."}],"balance_after":1000746,"source":{"system":"sec-edgar","filing":"0001764013-22-000122","document":"wf-form4_166448557706339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401322000122/wf-form4_166448557706339.xml","form_type":"4"}},{"id":2169027,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-01T11:36:15.000Z","date":"2022-08-30","kind":"sale","acquired":false,"shares":1644,"price":5.83,"value":9584.52,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 19, 2021, the holder was granted 132,500 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on March 23, 2021, of which 2,761 of these RSUs vested on August 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder."}],"balance_after":1002351,"source":{"system":"sec-edgar","filing":"0001764013-22-000112","document":"wf-form4_166203216200949.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401322000112/wf-form4_166203216200949.xml","form_type":"4"}},{"id":2178371,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-19T20:50:31.000Z","date":"2022-08-17","kind":"grant","acquired":true,"shares":678592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on August 17, 2023 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date."}],"balance_after":678592,"derivative":{"exercise_price":4.99,"expiration_date":"2032-08-17","underlying":"Common Stock","underlying_shares":678592},"source":{"system":"sec-edgar","filing":"0001764013-22-000099","document":"wf-form4_166094221021747.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401322000099/wf-form4_166094221021747.xml","form_type":"4"}},{"id":2178370,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-19T20:50:31.000Z","date":"2022-08-17","kind":"grant","acquired":true,"shares":451264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the number of shares underlying restricted stock units awards (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest over four years, with 25% of the RSUs vesting on August 17, 2023 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date."}],"balance_after":1003995,"source":{"system":"sec-edgar","filing":"0001764013-22-000099","document":"wf-form4_166094221021747.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401322000099/wf-form4_166094221021747.xml","form_type":"4"}},{"id":2200318,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-07-29T11:36:18.000Z","date":"2022-07-27","kind":"sale","acquired":false,"shares":1528,"price":4.27,"value":6524.56,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 19, 2021, the holder was granted 132,500 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on March 23, 2021, of which 2,760 of these RSUs vested on July 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder."}],"balance_after":552731,"source":{"system":"sec-edgar","filing":"0001764013-22-000077","document":"wf-form4_165909456363894.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401322000077/wf-form4_165909456363894.xml","form_type":"4"}},{"id":2217394,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-07-01T11:05:44.000Z","date":"2022-06-29","kind":"sale","acquired":false,"shares":1376,"price":4.02,"value":5531.52,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 19, 2021, the holder was granted 132,500 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on March 23, 2021, of which 2,761 of these RSUs vested on June 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.02 - $4.08 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":554259,"source":{"system":"sec-edgar","filing":"0001764013-22-000072","document":"wf-form4_165667352814683.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401322000072/wf-form4_165667352814683.xml","form_type":"4"}},{"id":2256858,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-25T20:23:29.000Z","date":"2022-05-24","kind":"sale","acquired":false,"shares":1471,"price":3.79,"value":5575.09,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 19, 2021, the holder was granted 132,500 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on March 23, 2021, of which 2,760 of these RSUs vested on May 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.79 - $3.82 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":555635,"source":{"system":"sec-edgar","filing":"0001764013-22-000045","document":"wf-form4_165351019453934.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401322000045/wf-form4_165351019453934.xml","form_type":"4"}},{"id":2263148,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(right to buy)","published_at":"2022-05-19T18:34:18.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":79600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."}],"balance_after":79600,"derivative":{"exercise_price":0.33,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":79600},"source":{"system":"sec-edgar","filing":"0001209191-22-030444","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919122030444/doc4.xml","form_type":"4"}},{"id":2287959,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-04-29T11:05:04.000Z","date":"2022-04-27","kind":"sale","acquired":false,"shares":1622,"price":4.72,"value":7655.84,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 19, 2021, the holder was granted 132,500 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on March 23, 2021, of which 2,760 of these RSUs vested on April 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder."}],"balance_after":557106,"source":{"system":"sec-edgar","filing":"0001764013-22-000041","document":"wf-form4_165123029015521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401322000041/wf-form4_165123029015521.xml","form_type":"4"}},{"id":2297012,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-04-14T11:16:28.000Z","date":"2022-03-24","kind":"sale","acquired":false,"shares":19227,"price":5.9,"value":113439.3,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 19, 2021, the holder was granted 132,500 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on March 23, 2021, of which 25% of these RSUs vested on March 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder."}],"balance_after":558728,"source":{"system":"sec-edgar","filing":"0001764013-22-000035","document":"wf-form4_164993497408514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401322000035/wf-form4_164993497408514.xml","form_type":"4"}},{"id":2437857,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-01-11T15:49:41.000Z","date":"2022-01-07","kind":"sale","acquired":false,"shares":125158,"price":7.25,"value":907395.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 3, 2021, the holder was granted 570,613 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on August 4, 2021, of which 37.5% of these RSUs vested on January 1, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs."}],"balance_after":577955,"source":{"system":"sec-edgar","filing":"0001764013-22-000009","document":"wf-form4_164191616856320.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401322000009/wf-form4_164191616856320.xml","form_type":"4"}},{"id":2570950,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-14T19:59:19.000Z","date":"2021-09-11","kind":"disposition_to_issuer","acquired":false,"shares":464700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on March 19, 2022 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date."}],"balance_after":0,"derivative":{"exercise_price":17,"expiration_date":"2031-03-19","underlying":"Common Stock","underlying_shares":464700},"source":{"system":"sec-edgar","filing":"0001764013-21-000095","document":"wf-form4_163164954372889.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401321000095/wf-form4_163164954372889.xml","form_type":"4"}},{"id":2570949,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-14T19:59:19.000Z","date":"2021-09-11","kind":"grant","acquired":true,"shares":464700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on March 19, 2022 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date."}],"balance_after":464700,"derivative":{"exercise_price":8.62,"expiration_date":"2031-03-19","underlying":"Common Stock","underlying_shares":464700},"source":{"system":"sec-edgar","filing":"0001764013-21-000095","document":"wf-form4_163164954372889.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401321000095/wf-form4_163164954372889.xml","form_type":"4"}},{"id":2570948,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-14T19:59:19.000Z","date":"2021-09-11","kind":"disposition_to_issuer","acquired":false,"shares":430700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the options vested on May 15, 2021, and the remainder vested or vests in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date."}],"balance_after":0,"derivative":{"exercise_price":19.01,"expiration_date":"2030-05-14","underlying":"Common Stock","underlying_shares":430700},"source":{"system":"sec-edgar","filing":"0001764013-21-000095","document":"wf-form4_163164954372889.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401321000095/wf-form4_163164954372889.xml","form_type":"4"}},{"id":2570947,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-14T19:59:19.000Z","date":"2021-09-11","kind":"grant","acquired":true,"shares":430700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the options vested on May 15, 2021, and the remainder vested or vests in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date."}],"balance_after":430700,"derivative":{"exercise_price":8.62,"expiration_date":"2030-05-14","underlying":"Common Stock","underlying_shares":430700},"source":{"system":"sec-edgar","filing":"0001764013-21-000095","document":"wf-form4_163164954372889.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401321000095/wf-form4_163164954372889.xml","form_type":"4"}},{"id":2615094,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-04T20:06:02.000Z","date":"2021-08-03","kind":"grant","acquired":true,"shares":570613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the number of shares underlying restricted stock units awards (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"37.5% of the RSUs will vest on January 1, 2022 and the remainder of the RSUs will vest on August 3, 2023, subject to the Reporting Person providing continuous service to the Issuer as of each such date."}],"balance_after":703113,"source":{"system":"sec-edgar","filing":"0001764013-21-000068","document":"wf-form4_162810753247468.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401321000068/wf-form4_162810753247468.xml","form_type":"4"}},{"id":2662900,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T20:45:05.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":58200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a special retention award comprised of options to purchase common stock. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."}],"balance_after":58200,"derivative":{"exercise_price":2.07,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":58200},"source":{"system":"sec-edgar","filing":"0001209191-21-041467","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919121041467/doc4.xml","form_type":"4"}},{"id":2662899,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T20:45:05.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":58200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."}],"balance_after":58200,"derivative":{"exercise_price":2.07,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":58200},"source":{"system":"sec-edgar","filing":"0001209191-21-041467","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919121041467/doc4.xml","form_type":"4"}},{"id":2775010,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-23T12:46:48.000Z","date":"2021-03-19","kind":"grant","acquired":true,"shares":464700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on March 19, 2022 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date."}],"balance_after":464700,"derivative":{"exercise_price":17,"expiration_date":"2031-03-19","underlying":"Common Stock","underlying_shares":464700},"source":{"system":"sec-edgar","filing":"0001764013-21-000040","document":"wf-form4_161650359586006.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401321000040/wf-form4_161650359586006.xml","form_type":"4"}},{"id":2775009,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-03-23T12:46:48.000Z","date":"2021-03-19","kind":"grant","acquired":true,"shares":132500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the number of shares underlying restricted stock units awards (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest over four years, with 25% of the RSUs vesting on March 19, 2022 and the remainder of the RSUs vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date."}],"balance_after":132500,"source":{"system":"sec-edgar","filing":"0001764013-21-000040","document":"wf-form4_161650359586006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401321000040/wf-form4_161650359586006.xml","form_type":"4"}},{"id":3136489,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(right to buy)","published_at":"2020-05-22T19:00:11.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":40500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."}],"balance_after":40500,"derivative":{"exercise_price":7.3,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":40500},"source":{"system":"sec-edgar","filing":"0001209191-20-031658","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919120031658/doc4.xml","form_type":"4"}},{"id":3145693,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-05-18T12:26:12.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":430700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vests on the first anniversary of the grant date, and the remainder vests in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date."}],"balance_after":430700,"derivative":{"exercise_price":19.01,"expiration_date":"2030-05-14","underlying":"Common Stock","underlying_shares":430700},"source":{"system":"sec-edgar","filing":"0001209191-20-029926","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000120919120029926/doc4.xml","form_type":"4"}},{"id":3217097,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(right to buy)","published_at":"2020-03-10T20:06:11.000Z","date":"2020-03-06","kind":"grant","acquired":true,"shares":66600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Incentive Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Incentive Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."}],"balance_after":66600,"derivative":{"exercise_price":4.53,"expiration_date":"2030-03-06","underlying":"Common Stock","underlying_shares":66600},"source":{"system":"sec-edgar","filing":"0001493152-20-003663","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000149315220003663/ownership.xml","form_type":"4"}},{"id":3334033,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":80700,"kind":"person","name":"Salzmann Peter","position":1,"cik":"0001796309","reported_name":"Salzmann Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-12-20T21:59:27.000Z","date":"2019-12-18","kind":"grant","acquired":true,"shares":1479043,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the share exchange transaction pursuant to which Health Sciences Acquisitions Corporation (\"HSAC\") acquired 100% of the issued and outstanding shares of Immunovant Sciences Ltd., the option to purchase 3,024,219 shares of Immunovant Sciences Ltd. at exercise price of $3.84 per share, was assumed by HSAC and converted into an option to purchase shares of the Issuer (formerly known as HSAC)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vests on the first anniversary of the grant date, and the remainder vests in 12 equal quarterly installments thereafter."}],"balance_after":1479043,"derivative":{"exercise_price":7.86,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":1479043},"source":{"system":"sec-edgar","filing":"0001209191-19-061600","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000120919119061600/doc4.xml","form_type":"4"}}]}